Next-Gen Molecular Solutions. Made for India.

At Bayosthiti AI, we’re transforming Indian healthcare with world-class, homegrown molecular testing solutions. Our mission is to revolutionise diagnosis, prognosis, and therapeutics through advanced molecular understanding.

Explore the Shift

Biology Secrets
Decoded with AI

Our scientific approach is based on creating a detailed molecular profile capturing data across multiple dimensions. Through deep transcriptomic profiling, we capture how genes are expressed at any given moment by measuring 30,000 of them from a single sample.

What Goes Behind the Innovation

Molecules Hold the Clues
We Bring the Answers

With sophisticated AI interpreting biological complexity, we enable advanced diagnostics, accurate prognosis, treatment selection, and accelerated development of therapeutics.

How we Help

A Deeper
Dive into the
Language of Life

By providing deep molecular insights across multiple dimensions, we uncover the underlying mechanisms governing our biological makeup.

See the Impact
a happy family new
About US

Care Within
Everyone's Reach

Affordable and Advanced. Designed for Every Indian Family.

Our innovations, from India’s most affordable NIPT tests and the largest region-specific infectious disease + antimicrobial resistance detection panels to personalized diagnostics through our breakthrough RNA-sequencing and AI-based platform, ensure patient-centric care without compromising quality.

Find the Right Test for You

Behind the Breakthroughs


  • Affordable Prenatal Care for All

     Making essential prenatal tests accessible for every expecting mother in India, without compromising on quality or accuracy

    Affordable Prenatal Care for All

     Making essential prenatal tests accessible for every expecting mother in India, without compromising on quality or accuracy

  • Tackling Infectious Disease and Antibiotic Resistance     Rapid diagnostics that identify infections and pinpoint effective antibiotics—tackling India’s growing antibiotic resistance crisis

    Tackling Infectious Disease and Antibiotic Resistance     Rapid diagnostics that identify infections and pinpoint effective antibiotics—tackling India’s growing antibiotic resistance crisis


  • Breakthrough RNA-Sequencing
    & AI     Decoding complex biological patterns using advanced RNA-sequencing and AI—enabling earlier, smarter, and more accurate diagnoses


    Breakthrough RNA-Sequencing
    & AI     Decoding complex biological patterns using advanced RNA-sequencing and AI—enabling earlier, smarter, and more accurate diagnoses


  • Strong Healthcare Partnerships
    Collaborating with leading institutions to deliver precise diagnostics and co-develop solutions for India’s pressing health challenges


    Strong Healthcare Partnerships
    Collaborating with leading institutions to deliver precise diagnostics and co-develop solutions for India’s pressing health challenges
Made in India,
Made for India

India’s first company offering comprehensive and affordable NIPT solutions, infectious disease screening and diagnostics, and a future-ready RNA-sequencing platform with advanced AI for early diagnosis, better prognosis and treatment; empowering providers with accessible tools for routine and bedside care

 

Explore Our Diagnostic Solutions
The Challenge

Access to
Prenatal Testing

  • Essential prenatal tests range between ₹10,000–₹15,000 in India
  • Advanced tests may even exceed as much as ₹25,000
  • Unaffordable and inaccessible for many Indian families
  • Only 15 lakh expecting mothers (out of 2.5 crore births per year) are aware of these tests

Our
Solution

NIPT tests made available at ≤ ₹5,000

making high-quality prenatal screening affordable

Expand awareness and accessibility

to every expecting mother

Maintain international quality standards

without compromising affordability

Fast turnaround times

with more accurate and reliable prenatal screening

The Challenge

Infectious Diseases
Antibiotic Resistance

  • Infections in India are 2–3 times more antibiotic-resistant than in developed nations
  • More than 60,000 lives are lost per year due to antibiotic resistance
  • More than ₹1000 crore spent on tackling antibiotic resistance in India

Our
Solution

Advanced diagnostic assays

pinpoint the infection source quickly and accurately

Identifies the most effective antibiotics

immediately, reducing trial-and-error prescriptions

Enables region-specific surveillance

to track and combat antimicrobial resistance trends

Prevents overuse of ineffective antibiotics

improving patient outcomes

The Challenge

Access to
Personalized Diagnostics

  • Population-level studies are prohibitively expensive
  • Advanced RNA-sequencing-based tests may exceed ₹25,000
  • AI-powered insights have so far been out of reach
  • Personalized diagnostics and precision medicine are not the norm in India

Our
Solution

Proprietary technology

to bring down the cost of RNA-sequencing by 2- 3x

Clinical trials

for diagnostics in heart disease and cancer, ushering in the era of AI-powered precision medicine

Personalised monitoring

and better treatment through early diagnosis

Affordable, accessible testing

by creating solutions specifically catering to the Indian population

Overview of Our Services

Proudly Indian.
Future-ready Healthcare Instruments


Stronger Together
Collaborating for
Impactful Healthcare

Partnership Framework

Stronger Together. Collaborating
for Impactful Healthcare

We invest in strong, strategic partnerships with leading institutions in India’s healthcare ecosystem. These partnerships are multifaceted, covering four key dimensions:

Clinical Service Relationship

  • Partner institutions become early adopters of our technologies
  • We provide access to cost-effective RNA sequencing, multiplexed testing
  • AI-powered diagnostic and prognostic tools are embedded into clinical workflows

  • We offer preferential pricing to ensure accessibility with uncompromised  quality

Research Collaboration

  • We jointly develop AI-driven healthcare solutions tailored to clinical needs
  • Partners collect biological samples and clinical data for insights and innovation
  • Collaborative design of disease-specific diagnostic panels

  • Shared peer-reviewed publication framework

Clinical Validation Partnership

  • We assist with regulatory approvals and trials through expert guidance
  • Partners support validation via patient recruitment and data collection
  • Standardised protocols are co-developed to ensure consistency and compliance

  • We aid CDSCO registration and maintain quality across deployments

Market Development

  • Our technologies are deployed across partner networks for deeper impact
  • We engage in joint market expansion to reach underserved populations
  • We ensure integration with national healthcare programs and initiatives
  • Partners co-develop diagnostic applications for emerging medical needs

What We Look for in a Partner

Clinical & Research Excellence

Strong clinical expertise with proven research capabilities

Patient & Biobank Access

Significant patient volumes and biobanks in target disease areas

Quality & Compliance

Established quality control systems and regulatory compliance

Reach and Presence

Wide reach and strong presence in key healthcare regions

Clinical Trial & Regulatory Experience

Hands-on expertise in clinical trials and regulatory processes

Data & Innovation Readiness

Advanced data management and a commitment to healthcare innovation

Through these partnerships, we aim to create a robust ecosystem that supports our scientific objectives while contributing to the advancement of healthcare in India. Contact partnerships@bayosthiti.ai

ww2150041842

Regulatory & Compliance
Assurance

  • 01. Gold-Standard Validation → All our instruments and products CLIA/CDSCO-validated
    → Tested against gold standards in their respective application areas
  • 02. Strict Clinical Trial Compliance → We adhere to regulatory, data management, and patient safety protocols
    → We are conducted under Ethics Committee oversight

For more details, contact us at partnerships@bayosthiti.ai

ww2150041842
Partner Voices

Feedback from a clinical
laboratory partner

  • The nucleic acids of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Staphylococcus aureus, and Candida albicans were mixed with human DNA to simulate three positive samples, while three negative samples were obtained using human DNA alone. Thirteen target pathogens (five target sequences for each pathogen) were extracted from the tNGS project’s target sequence database.

    DIMPLE was employed for primer design, generating one pair of primers for each target sequence, resulting in a total of 65 primer pairs for subsequent experimental validation and analysis. The conclusions are as follows:

    (1) No obvious primer dimers were detected in the multiplex PCR and fragment analysis;

    (2) All pathogens in the positive samples were successfully detected, while none were detected in the negative samples;

    (3) Amplification was efficient for 64 primer pairs, except for one pair (Candida albicans No.5 primer), which exhibited poor amplification efficiency.
  • Overall, the primers designed by DIMPLE demonstrated excellent performance, enabling the detection of the target pathogens.

    - Jiaqi Liu (Director of R&D)

Insights That Matter

From Puppies to Low-Cost RNA-seq: Step 0 in Eliminating Animal Testing

What Biologists can learn from LLMs

Quacking the code: Bridging the animal-human divide

When “Detecting Everything” misses the point

Biology as clockwork

For Inquiries in India
  • +91-7975311056
  • Office Location: Center for Cellular and Molecular Platforms, C-CAMP GKVK Post, Bellary Rd, Bengaluru, Karnataka 560065
  • partnerships@bayosthiti.ai

Bayosthiti AI is India’s first comprehensive molecular profiling and diagnostics company. Through our cutting-edge molecular solutions ranging from advanced NIPT and infectious disease testing to RNA-sequencing-based personalized healthcare, we are making precision medicine accessible to all.

Speak To Our Specialist
  • +91-7975311056
Roadmap